-
effectivehealthcare-admin.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research-protocol
December 01, 2019 - the spectrum and is characterized by the neoplastic proliferation of a clone of plasma cells in the bone … marrow plasma cells ≤10%
Absence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … of end-organ damage (bone lesions, anemia, hypercalcemia, or renal failure)
20% of multiple … Bone marrow biopsy.
Skeletal lesions. … marrow biopsies, and bone scans.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
September 13, 2013 - lack of strong evidence for an association of vitamin D and calcium status with conditions other
than bone … For bone health outcomes, only RCTs of greater than 1 year in duration will be
included. … content; BMD = bone mineral density; CVD = cardiovascular disease; UV = ultraviolet light … health clinical outcomes (rickets, fracture, falls, or muscle strength)
• Bone health intermediate … outcomes (bone mineral density or content)
• Dose-response relationship between intake levels and
-
effectivehealthcare-admin.ahrq.gov/health-topics/vitamin-d
March 01, 2023 - Calcium is one of the main building blocks of bone. … A lack of vitamin D can lead to bone diseases such as osteoporosis or rickets . … 14, 2010
Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone
-
effectivehealthcare-admin.ahrq.gov/products/vitamin-d-calcium/research-protocol
December 01, 2019 - lack of strong evidence for an association of vitamin D and calcium status with conditions other than bone … and calcium intake on surrogate or intermediate outcomes, such as hypertension, blood pressure, and bone … Abbreviations: 1,25(OH)2D = 1,25-dihydroxyvitamin D; 25(OH)D = 25-hydroxyvitamin D;BMC = bone mineral … content; BMD = bone mineral density; CVD = cardiovascular disease; UV = ultraviolet light
Figure 2 … (bone mineral density or content)
Dose-response relationship between intake levels and indicators
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - includes insulin-like growth factors, protein turnover markers, nutritional status, growth measures, bone … variables, insulin-like growth factor variables, hospitalization, bone fracture, health-related quality … The final health outcomes include mortality, hospitalization, bone fracture, and health-related quality … mineralization are associated with improvements in health outcomes of quality of life, bone fracture … mineralization are associated with improvements in health outcomes of quality of life, bone fracture
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
November 01, 2010 - transplantation (HSCT) refers to a procedure in which
hematopoietic stem cells are infused to restore bone … nonmalignant diseases, donor hematopoietic stem cells are used to
“replace” the patient’s abnormal bone … brain tumors, and those derived from the peripheral nervous system
(neuroblastoma), soft tissues or bone … conditions may also be treated with HSCT, and in the
pediatric population include hemoglobinopathies, bone … lymphoblastic leukemia; allo: allogeneic; AML: acute myelogenous leukemia; auto: autologous; BMF:
bone
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
May 02, 2011 - Monoclonal gammopathy of
undetermined
significance (MGUS)
Serum monoclonal protein ≤ 3g/dL
Bone … marrow plasma cells ≤10%
Absence of end-organ damage (bone lesions, anemia,
hypercalcemia, or renal … Asymptomatic
1% per year progress to
multiple myeloma or
related PCD
Multiple myeloma Bone … marrow immunostaining
Serum monoclonal protein ≥3 g/dL and/or bone marrow
plasma cells ≥10%
… marrow biopsies, and bone
scans
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - Up-to-date Up-to-date
Bone
mineralization:
Bone age: 2
November 2011
No new evidence
July 2012 … [mh] OR
"bone fracture*" OR "broken bone*" OR neoplasms[mh] OR neoplas* OR malignan* OR cancer OR
cancers … [mh] OR
"bone fracture*" OR "broken bone*" OR neoplasms[mh] OR neoplas* OR malignan* OR cancer OR
cancers … However, bone mineral
content does significantly improve with
rhGH therapy in trials, and bone mineral … Bone Consequences and Protein
Turnover/Exercise Tolerance/Bone
Mineralization:
No studies evaluated
-
effectivehealthcare-admin.ahrq.gov/products/cystic-fibrosis-hgh/research-protocol
December 01, 2019 - change in FEV1); growth (height, weight, lean body mass, protein turnover); exercise tolerance; and bone … mineralization are associated with improvements in health outcomes of quality of life, bone fracture … mineralization, bone fracture or development of osteoporosis/osteopenia, mortality, glucose measures … Fractures, Bone/
36. bone fracture$.mp.
37. broken bones.mp.
38. … Fractures, Bone/
11. bone fracture$.mp.
12. broken bones.mp.
13.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0320_06-17-2009.pdf
January 01, 2009 - patients presenting with any of the non-specific complaints associated with
these diseases (i.e., bone … savings (e.g., decreased length of stay and number of clinic visits); decreased whole
body scans or bone … Are the number of bone marrow biopsies and/or whole body scans decreased in
NSMM when FLCs are measured
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
August 22, 2008 - CF, what is the strength of evidence that intermediate outcomes of
pulmonary function, growth, and bone … mineralization are associated with improvements in
health outcomes of quality of life, bone fracture … mineralization, bone fracture or development of
osteoporosis/osteopenia, mortality, glucose measures … Fractures, Bone/
36. bone fracture$.mp.
37. broken bones.mp.
38. … Published Online: January 22, 2010 15
11. bone fracture$.mp.
12. broken bones.mp.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
August 01, 2012 - after treatment and provide
prognostic information,9,10 potentially reducing the need
for frequent bone … AL amyloidosis), does the use of the SFLC
assay reduce the need for other diagnostic tests (e.g., bone … One C-quality retrospective study assessed the need for
bone marrow examination, with the SFLC assay … The authors concluded
it was not possible to eliminate the need for bone marrow
testing to evaluate … Bone Marrow Transplantation. 2005 Oct;36(7):597-600.
11. Katzmann JA.
-
effectivehealthcare-admin.ahrq.gov/products/breast-cancer-imaging/technical-brief
December 01, 2019 - Findings
We identified bone scan (scintigraphy), magnetic resonance imaging (MRI), computed tomography … general, uptake of tracers such as FDG in PET/CT scans is associated with tumor response as determined by bone … Systematic Review
Systematic Review
Aug 29, 2023
Radiation Therapy for Metastatic Bone
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/dp5_maps.pdf
June 22, 2011 - DataPoints5Maps_heartlung[1].pdf
DataPoints5Maps_rehab[1].pdf
DataPoints5Maps_urethra&bone[1].pdf
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
July 01, 2023 - Some cancer treatments are associated with an increased risk of severe deterioration of
the bones of … tissue. … It is standard practice to delay beginning bisphosphonates or other agents that act directly on
bones … Bone Marrow Transplant. 1988
Jan;3(1):43-51. PMID: 3048469.
47. … The presenting
dental status of solid tumours with bone
metastases requiring bone-targeting agents
-
effectivehealthcare-admin.ahrq.gov/health-topics/bruises
You can get skin, muscle and bone bruises. Bone bruises are the most serious.
-
effectivehealthcare-admin.ahrq.gov/products/cystic-fibrosis-hgh/research
December 01, 2019 - 95 percent CI 7.01 to 18.12), lean body mass (LBM) (WMD 1.92 kg, 95 percent CI 1.47 to 2.37 kg)] and bone … strength (bone mineral content (WMD 192 g, 95 percent CI 110 to 273 g)] were significantly improved … IV antibiotic use during therapy, pulmonary exacerbations, health-related quality-of-life (HRQoL), bone … Improvements in bone mineral content are also promising.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
March 01, 2012 - Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or … Comments Report
Research Review Title: Treatment to Prevent Fractures in Men and Women with Low Bone … mass and produced bone that was normal (e.g., no
qualitative abnormalities). … Bone. 2011 Apr 1;48(4):677-92. Epub 2010 Dec 9. … The use of markers of bone turnover is not part of the scope of
the review.
-
effectivehealthcare-admin.ahrq.gov/products/vitamin-d-calcium/research
December 01, 2019 - with calcium on selected health outcomes included in the earlier review: primarily those related to bone … Available evidence focused mainly on bone health, cardiovascular diseases, or cancer outcomes. … Findings were inconsistent across studies for bone health; breast, colorectal, and prostate cancer; cardiovascular … cardiovascular outcomes, all-cause mortality, several types of cancer, and intermediate outcomes for bone
-
effectivehealthcare-admin.ahrq.gov/products/breast-cancer-imaging/research-protocol
December 01, 2019 - Approximately 5 percent were diagnosed with distant metastases, most commonly to the bones, lungs, liver … resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), PET-CT, and bone … PET-CT 12 and abdominal ultrasound are also widely used. 11 For patients with bone-only metastases, … bone scans are the most common imaging modality, with supplemental use of x-ray, CT, MRI and/or PET-CT … Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.